EMA begins early advice pilot to improve pediatric drug development
This article was originally published in SRA
Executive Summary
The European Medicines Agency is offering companies free early advice on the pediatric aspects of drug development, in order to help them make their development programs more efficient and ultimately speed up access to new drugs for children.